1253186-46-7
1253186-46-7
Chemical Structure
GSK-5503A
- CAS No.: 1253186-46-7
- Formula:C23H17F2N3O2
- Molecular Weight:405.40
IUPAC Name: 2,6-difluoro-N-(1-(2-phenoxybenzyl)-1H-pyrazol-3-yl)benzamide
InChIKey: FFTYDCLYIJBUCD-UHFFFAOYSA-N
SMILES: O=C(NC1=NN(CC2=CC=CC=C2OC3=CC=CC=C3)C=C1)C4=C(F)C=CC=C4F
Biological Activity: GSK-5503A is a calcium-release activated calcium (CRAC) channel blocker. GSK-5503A effectively inhibits stromal interaction molecule 1 (STIM1) mediated Orai1 and Orai3 currents in vitro. GSK-5503A can be used for the research of asthma and allergic disorders[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK-5503A | GSK-5503A is a calcium-release activated calcium (CRAC) channel blocker. GSK-5503A effectively inhibits stromal interaction molecule 1 (STIM1) mediated Orai1 and Orai3 currents in vitro. GSK-5503A can be used for the research of asthma and allergic disorders. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
